InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Klein Lawrence Otto, Chief Operating Officer. Director active across 1 companies, notably CRISPR Therapeutics AG. Aggregated, 5 filings have been recorded. Regulator: SEC (Form 4). All data is free.
Declarations5 total
4,584 shares
Common Shares
SEC:0001209191-22-018611:0·
26,667 shares
Common Shares
SEC:0001209191-21-068455·
26,667 shares
Common Shares
SEC:0001209191-21-068455:0·
10,000 shares
Common Shares
SEC:0001209191-21-056092·
10,000 shares
Common Shares
SEC:0001209191-21-056092:0·
5 of 5 declarations
About Klein Lawrence Otto
Lawrence Otto Klein is the Chief Business Officer and Chief Operating Officer at CRISPR Therapeutics AG. He oversees the company's commercial and strategic operations, playing a crucial role in implementing growth strategy. With a strong background in the biopharmaceutical sector, Lawrence Otto Klein is committed to advancing the company's objectives and maximizing its market impact.
